这管我啥事。你不是让拿出份高的数据看看嘛假如mrna也选三个发展中国家做三期，然后不加任何政治干涉，疫苗供应威胁。 如果拿到三个90%，那就没话说了。它万一也拿到一个50%，那也就变50%了。
只在自己国家做，没啥用。
谁和你说辉瑞和bnt只在自己国家做的phase3?
辉瑞作为一个大厂连数据要diversity这都不知道?
https://www.businesswire.com/news/home/20201118005595/en/
from approximately 150 clinical trials sites in United States, Germany, Turkey, South Africa, Brazil and Argentina
40000多人，这有几个是发展中国家吧。
https://www.businesswire.com/news/home/20201118005595/en/
from approximately 150 clinical trials sites in United States, Germany, Turkey, South Africa, Brazil and Argentina
40000多人，这有几个是发展中国家吧。
[本文发送自华新手机Wap版]
Huasing Association 1999 - 2013